Intravenous Infusions Limited (IIL)
0.04
0.00%
0.00
Fri, 26 May 2023
@Fri, 26 May 2023
GSE-CI 2,519.92 0.91(-0.04%)arrow_drop_down
GSE-FI 1,677.69 0.00(0.00%)remove
Market Cap 65,330.48 9.51(-0.01%)arrow_drop_down
AADS 0.41 0.00(0.00%)remove
ACCESS 4.00 0.00(0.00%)remove
ADB 5.06 0.00(0.00%)remove
AGA 37.00 0.00(0.00%)remove
ALW 0.10 0.00(0.00%)remove
ASG 8.87 0.00(0.00%)remove
BOPP 13.00 1.11(-7.87%)arrow_drop_down
CAL 0.50 0.00(0.00%)remove
CLYD 0.03 0.00(0.00%)remove
CMLT 0.10 0.00(0.00%)remove
CPC 0.02 0.00(0.00%)remove
DASPHARMA 0.40 0.00(0.00%)remove
DIGICUT 0.09 0.00(0.00%)remove
EGH 5.40 0.00(0.00%)remove
EGL 2.43 0.00(0.00%)remove
ETI 0.15 0.00(0.00%)remove
FML 1.30 0.10(+8.33%)arrow_drop_up
GCB 3.15 0.00(0.00%)remove
GGBL 1.65 0.00(0.00%)remove
GOIL 1.65 0.00(0.00%)remove
RBGH 0.54 0.00(0.00%)remove
HORDS 0.10 0.00(0.00%)remove
IIL 0.04 0.00(0.00%)remove
MAC 5.38 0.00(0.00%)remove
MMH 0.11 0.00(0.00%)remove
MTNGH 1.10 0.00(0.00%)remove
PBC 0.02 0.00(0.00%)remove
POP 0.68 0.00(0.00%)remove
SAMBA 0.55 0.00(0.00%)remove
SCB 12.50 0.00(0.00%)remove
SCBPREF 0.90 0.00(0.00%)remove
SOGEGH 0.60 0.00(0.00%)remove
SIC 0.25 0.00(0.00%)remove
TBL 0.82 0.00(0.00%)remove
TOTAL 6.45 0.00(0.00%)remove
TLW 11.92 0.00(0.00%)remove
UNIL 6.08 0.28(+4.83%)arrow_drop_up
| Open | 0.04 |
| High | - |
| Low | - |
| Close | 0.04 |
| Closing Bid | 0.00 |
| Closing Offer | 0.00 |
| Last Transaction Price | 0.04 |
| Volume | 0 |
| Value | 0.00 |
| Ex-Dividend | - |
| YTD % | - |
| Beta | -0.0698 |
| 52-Wk Range | 0.04 - 0.04 |
| Avg Val (3m) | 2.99 |
| Market Cap (GHS mn) | 10.35 |
| EPS (ttm) | -0.01 |
| PE (ttm) | - |
| PB | 0.53 |
| Earnings Yield % | - |
| Dividend Yield % | - |
| 3-Year % | 33.33 |
-
GSE extends time for 6 listed companies to submit financial results
The Ghana Stock Exchange announces for the information of the general investing public that, the underlisted Listed Companies have sought permission for the extension of time to submit their audited Financial Statements for the year ended December 31, 2019:
i. Enterprise Group Limited – Apr
-
Intravenous Infusions raises GHS3.22mn in private placement
-
IIL appoints new Director to its Board
-
Intravenous Infusions to raise additional equity capital of GHS5.43mn
-
Intravenous Infusions appeal for trade barrier removal
